Drug Approval | January 28, 2024
Shilpa Medicare updates on Europe GMP inspection at Unit 4, Jadcherla, Telangana
The company intends to respond to the two minor observations within the stipulated time
The company intends to respond to the two minor observations within the stipulated time
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
The new campus has been designed as an employee-centred experience and ecosystem zone
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
He is a former Neurology faculty member at The Johns Hopkins Hospital and an elected Fellow of the Royal College of Physicians, United Kingdom
The company also plans to boost its India presence by adding 1,500 beds in the next 2-3 years
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme
Subscribe To Our Newsletter & Stay Updated
